Minireview: Switching on progesterone receptor expression with duplex RNA

Molecular Endocrinology

Volumn 24, Issue 12, 2010, Pages 2243-2252

  Janowski, Bethany A ^a   Corey, David R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENE RNA; ARGONAUTE 2 PROTEIN; DOUBLE STRANDED RNA; MESSENGER RNA; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; DNA HYBRIDIZATION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; MAMMAL CELL; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA SEQUENCE; SHORT SURVEY; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; RNA, DOUBLE-STRANDED; RNA, SMALL INTERFERING;

EID: 78649400666     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0067     Document Type: Short Survey

References (72)

1. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, et al. 2005 The transcriptional landscape of the mammalian genome. Science [Erratum (2006) 311:1713] 309:1559-1563
2. Gingeras TR 2007 Origin of phenotypes: genes and transcripts. Genome Res 17:682-690
3. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J, Hofacker IL, Bell I, Cheung E, Drenkow J, Dumais E, Patel S, Helt G, Ganesh M, Ghosh S, Piccolboni A, Sementchenko V, Tammana H, Gingeras TR 2007 RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316:1484-1488 (Pubitemid 46906616)
4. He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW 2008 The antisense transcriptomes of human cells. Science 322: 1855-1857
5. Trash-Bingham CA, Tartof KD 1999 αHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst 91:143-151
6. Volloch V, Schweitzer B, Rits S 1996 Antisense globin RNA in mouse erythroid tissues: structure, origin, and possible function. Proc Natl Acad Sci USA 93:2476-2481
7. Yochum GS, Cleland R, McWeeney S, Goodman RH 2007 An antisense transcript induced by Wnt/β-Catenin signaling decreases E2F4. J Biol Chem 282:871-878
8. Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K, Marsden PA 2004 Post-transcriptional regulation of endothelial nitric oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem 279:37982-37996
9. Wahlestedt C 2006 Natural sense and noncoding RNA transcripts as potential drug targets. Drug Discov Today 11:503-508
10. Faghihi MA, Wahlestedt C 2009 Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10:637-643
11. Farnebo M 2009 Wrap53, a novel regulator of p53. Cell Cycle 8:2343-2346
12. Wu L, Belasco JG 2008 Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29:1-7
13. Carthew RW, Sontheimer EJ 2009 Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655
14. Bartel DP 2009 MicroRNAs: target recognition and regulatory functions. Cell 136:215-233
15. Brodersen P, Voinnet O 2009 Revisiting the principles of microRNAs target recognition. Nat Rev Mol Cell Biol 10:141-148
16. Wassenegger M, Heimes S, Riedel L, Sänger HL 1994 RNA-directed de novo methylation of genomic sequences in plants. Cell 76:567-576 (Pubitemid 24064176)
17. Matzke M, Kanno T, Huettel B, Daxinger L, Matzke AJ 2007 Targets of RNA-directed DNA methylation. Curr Opin Plant Biol 10:512-519
18. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA 2002 Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297:1833-1837
19. Grewal SI, Elgin SC 2007 Transcription and RNA interference in the formation of heterochromatin. Nature 447:399-406
20. Liu Y, Taverna SD, Muratore TL, Shabanowitz J, Hunt DF, Allis CD 2007 RNAi-dependent H3K27 methylation is required for heterochromatin formation and DNA elmination in Tetrahymena. Genes Dev 21:1530-1545 (Pubitemid 46955725)
21. Pal-Bhadra M, Leibovitch BA, Gandhi SG, Rao M, Bhadra U, Birchler JA, Elgin SC 2004 Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303:669-672
22. Grimaud C, Bantignies F, Pal-Bhadra M, Ghana P, Bhadra U, Cavalli G 2006 RNAi components are required for nuclear clustering of Polycomb group response elements. Cell 124:957-971
23. Huisinga KL, Elgin SC 2009 Small RNA-directed heterochromatin formation in the context of development: what flies might learn from fission yeast. Biochim Biophys Acta 1789:3-16
24. Morris KV, Chan SW, Jacobsen SE, Looney DJ 2004 Small interfering RNA-induced transcriptional silencing in human cells. Science 305:1289-1292
25. Kawasaki H, Taira K 2004 Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431:211-217
26. Taira K 2006 Retraction: induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 441:1176
27. Janowski BA, Kaihatsu K, Huffman KE, Schwartz JC, Ram R, Hardy D, Mendelson CR, Corey DR 2005 Inhibiting transcription of chromosomal DNA using antigene peptide nucleic acids. Nat Chem Biol 1:210-215
28. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614 (Pubitemid 120026050)
29. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW 2002 Reproductive functions of progesterone receptors. Recent Prog Horm Res 57:339-355
30. Spencer TE, Bazer FW 2002 Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front Biosci 7:d1879-d1898
31. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
32. Janowski BA, Huffman KE, Schwartz JC, Ram R, Hardy D, Shames DS, Minna JD, Corey DR 2005 Inhibiting gene expression at transcription start sites in chromosomal DNA by antigene RNAs. Nat Chem Biol 1:216-222
33. Janowski BA, Huffman KE, Schwartz, JC, Ram R, Nordsell R, Shames DS, Minna JD, Corey DR 2006 Involvement of Ago1 and Ago2 link mammalian transcriptional silencing with RNAi. Nat Struct Mol Biol 13:787-792
34. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T 2004 Human argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15:185-197
35. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ 2004 Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-1441 (Pubitemid 39167657)
36. Schwartz JC, Younger ST, Nguyen NB, Hardy DB, Monia BP, Corey DR, Janowski BA 2008 Antisense transcripts are targets for small RNAs. Nat Struct Mol Biol 15:842-848
37. Ting AH, Schuebel KE, Herman JG, Baylin SB 2005 Short double-stranded RNA induces transcriptional gene silencing in human cells in the absence of DNA methylation. Nat Genet 37:906-910
38. Han J, Kim D, Morris KV 2007 Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci USA 104:12422-12427
39. Kim DH, Villeneuve LM, Morris KV, Rossi JJ 2006 Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 13:793-797
40. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV 2009 Promoter-specific transcriptional interference and c-myc gene by siRNAs in human cells. EMBO J 28:1708-1719
41. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV 2009 Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 37:2984-2995
42. Pulukuri SM, Rao JS 2007 Small-interfering RNA-directed reversal of urokinase plasminogen activator dimethylation inhibits prostate tumor growth and metastasis. Cancer Res 67:6637-6646
43. Suzuki K, Shijuuku T, Fukamachi T, Zaunders J, Guillemin G, Cooper D, Kelleher A 2005 Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J RNAi Gene Silencing 1:66-78
44. Zhang MX, Ou H, Shen YH, Wang J, Wang J, Coselli J, Wang XL 2005 Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 102:16967-16972 (Pubitemid 41692667)
45. Alló M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, Agirre E, Plas M, Eyras E, Elela SA, Klinck R, Chabot B, Kornblihtt AR 2009 Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol 16:717-724
46. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR 2007 Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3:166-173 (Pubitemid 46271092)
47. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H, Dahiya R 2006 Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 103:17337-17342
48. Chen Z, Place RF, Jia ZJ, Pookot D, Dahiya R, Li LC 2008 Antitumor effect of dsRNA-induced p21WAF1/CIP1 gene activation in human bladder cancer cells. Mol Cancer Ther 7:698-703
49. Morris KV, Santoso S, Turner A-M, Pastori C, Hawkins PG 2008 Bidirectional transcription directs both transcription gene activation and suppression in human cells. PLOS Genet 4:1-3
50. Yamashita R, Wakaguri H, Sugano S, Suzuki Y, Nakai K 2010 DBTSS provides a tissue specific dynamic view of transcription start sites. Nucleic Acids Res 38:D98-D104
51. Olejniczak M, Galka P, Krzyzosiak WJ 2010 Sequence-non-specific effects of RNA interference triggers and microRNAs regulators. Nucleic Acids Res 38:1-16
52. Jackson AL, Linsley PS 2010 Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9:57-67
53. Yue X, Schwartz JC, Younger ST, Chu Y, Gagnon KT, Elbashir S, Janowski BA, Corey DR 27 June 2010 Regulation of transcription by small RNAs complementary to sequences downstream from the 3′ termini of genes. Nat Chem Biol 10.1038/nchembio.400
54. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS 1988 Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 122:935-944
55. Cho H, Aronica SM, Katzenellenbogen BS 1994 Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-1, and serum factors. Endocrinology 134:658-664 (Pubitemid 24980301)
56. Zaragoza DB, Wilson RR, Mitchell BF, Olson DM 2006 The interleukin 1β-induced expression of human prostaglandin F2a receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFκB. Biol Reprod 75:697-704
57. Stoica A, Saceda M, Doraiswamy VL, Coleman C, Martin MB 2000 Regulation of estrogen receptor-a gene expression by epidermal growth factor. J Endocrinol 165:371-378 (Pubitemid 30341086)
58. Tan-Wong SM, French JD, Proudfoot NJ, Brown MA 2008 Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene. Proc Natl Acad Sci USA 105:5160-5165
59. Tiwari VK, McGarvey KM, Lichesi JDF, Ohm JE, Herman JG, Schbeler D, Baylin SB 2008 PcG proteins, DNA methylation, and gene repression by chromatin looping. PLOS Biol 6:2911-2927
60. Tsai CL, Rowntree RK, Cohen DE, Lee JT 2008 Higher order chromatin structure at the X-inactivation center via looping DNA. Dev Biol 319:416-425
61. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R 2008 MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105:1608-1613
62. Kim DH, Saetrom P, Snove Jr O, Rossi JJ 2008 MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 105:16230-16235
63. Younger ST, Pertsemlidis A, Corey DR 2009 Predicting potential miRNA target sites within gene promoters. Bioorg Med Chem Lett 19:3791-3794
64. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW 1999 A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27
65. Leygue E 2007 Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer. Nuc Recept Signal 5:e006
66. Colley SM, Iyer KR, Leedman PJ 2008 The RNA coregulator SRA, its binding proteins and nuclear receptor signalling activity. IUBMB Life 60:159-164
67. Cassiday LA, Maher III LJ 2002 Having it both ways: transcription factors that bind RNA and DNA. Nucleic Acids Res 30:4118-4126
68. Hatchell EC, Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles KM, Redfern AD, Miles LE, Barker A, MacDonald LM, Arthur PG, Lui JC, Golding JL, McCulloch RK, Metcalf CB, Wilce JA, Wilce MC, Lanz RB, O'Malley BW, Leedman PJ 2006 SLIRP, a small SRA binding protein is a nuclear corepressor. Mol Cell 22:657-668 (Pubitemid 43817609)
69. Xu B, Yang WH, Gerin I, Hu CD, Hammer GD, Koenig RJ 2009 Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 29:1719-1734
70. Foulds CE, Tsimelzon A, Long W, Le A, Tsai SY, Tsai MJ, O'Malley BW 2010 Research source: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Mol Endocrinol 24:1090-0105
71. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP 2010 Noncoding RNA Gas5 is a growth arrest and starvation associated repressor of the glucocorticoid repressor. Science Signalling 3:ra8
72. Perales R, Bentley D 2009 "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol Cell 36:178-191